Pluri (PLUR) Defensive Interval Ratio


PLUR Pluri Inc PLUR
29 GF Score
Price $1.72
GF Value $6.52
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Pluri Defensive Interval Ratio?

PLUR
29GF Score
Pluri Inc PLUR
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pluri (PLUR) Overvalued in 2026?

Based on GuruFocus' analysis, Pluri stock appears to be undervalued. The current stock price of $1.72 is trading 73.7% below its estimated GF Value™ of $6.52. GuruFocus considers Pluri to be Possible Value Trap.

Key valuation signals for PLUR:

  • Defensive Interval Ratio:
  • GF Value™: $6.52 vs. price of $1.72 (73.7% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the PLUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pluri Business Description

Other Exchanges PLUR:Israel
Address MATAM Advanced Technology Park, Building No. 5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
29GF Score

Get the complete analysis for PLUR

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price
$6.52
GF Value